Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

PureCircle Ltd Receives FDA GRAS No Objection For New Rebaudioside D Stevia Sweetener


Tuesday, 9 Jul 2013 02:00am EDT 

PureCircle Ltd announced that the United States Food and Drug Administration (FDA) has issued a No Objection letter for the use of PureCircle's Rebaudioside D (Reb D) as a general purpose sweetener for foods and beverages in the US. PureCircle research has identified high purity Reb D as having one of the sweetness profiles of any steviol glycoside from the stevia leaf. 

Related Company News

Company Quote

607.5
-7.5 -1.22%
16 Apr 2014